Long-duration Parkinson's disease: Role of lateralization of motor features

被引:35
|
作者
Munhoz, Renato P. [1 ]
Espay, Alberto J. [2 ]
Morgante, Francesca [3 ]
Li, Jie-Yuan [4 ,5 ]
Teive, Helio A. [1 ]
Dunn, Emily [2 ]
Gallin, Eliza [6 ]
Litvan, Irene [6 ]
机构
[1] Univ Fed Parana, Movement Disorders Unit, Neurol Serv, Hosp Clin, BR-80060000 Curitiba, Parana, Brazil
[2] Univ Cincinnati, Gardner Family Ctr Parkinsons Dis & Movement Diso, Dept Neurol, Cincinnati, OH USA
[3] Univ Messina, Dipartimento Neurosci Sci Psichiatr & Anestesiol, Messina, Italy
[4] Kaohsiung Vet Gen Hosp, Div Neurol, Kaohsiung, Taiwan
[5] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan
[6] Univ Louisville, Sch Med, Dept Neurol, Div Movement Disorders, Louisville, KY 40292 USA
关键词
Parkinson's disease; Longevity; Handedness; SLEEP BEHAVIOR DISORDER; NONMOTOR SYMPTOMS; HANDEDNESS; LEVODOPA; PROGRESSION; DIAGNOSIS; SUBTYPES; DECLINE; ONSET;
D O I
10.1016/j.parkreldis.2012.07.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: A mean of 10 years elapse before patients with Parkinson's disease (PD) reach Hoehn & Yahr (H&Y) stage 4, and 14 years for stage 5. A small proportion of PD patients survive and are ambulatory for >= 20 years. We sought to identify features associated with long-duration PD (dPD). Methods: This five-center, case-control study compared 136 PD patients with >= 20 years of duration and H&Y stage <= 4 (dPD) to 134 H&Y-, age- and gender-matched PD patients between 10 and 15 years of disease (cPD). Results: By study design, there were no between-group differences in age, gender and H&Y. dPD subjects were younger at onset (p < 0.0001), had more psychosis (p: 0.038), were receiving higher levodopa equivalent daily doses (p: 0.02), were predominantly left-handed (p: 0.048), and had greater frequency of left-sided onset (p: 0.015) compared to cPD subjects. Both groups had similar rates of resting tremor, dementia and REM sleep behavior disorder. Conclusions: Early disease onset, left-handedness and left-sided onset are associated with long disease and ambulatory PD survival. The neurobiological basis of the prognostic value of lateralization deserves further investigation. (C) 2012 Published by Elsevier Ltd.
引用
收藏
页码:77 / 80
页数:4
相关论文
共 50 条
  • [1] The role of the long-duration response to levodopa in Parkinson's disease
    Zappia, Mario
    Nicoletti, Alessandra
    JOURNAL OF NEUROLOGY, 2010, 257 : S284 - S287
  • [2] The role of the long-duration response to levodopa in Parkinson’s disease
    Mario Zappia
    Alessandra Nicoletti
    Journal of Neurology, 2010, 257 : 284 - 287
  • [3] Motor response to apomorphine in patients with Parkinson's disease with long-duration response to levodopa
    Bonuccelli, U
    Napolitano, A
    Del Dotto, P
    Quattrone, A
    CLINICAL NEUROPHARMACOLOGY, 2002, 25 (02) : 119 - 121
  • [4] Long-Duration Response to Levodopa, Motor Learning, and Neuroplasticity in Early Parkinson's Disease
    Sciacca, Giorgia
    Mostile, Giovanni
    Disilvestro, Ivano
    Donzuso, Giulia
    Nicoletti, Alessandra
    Zappia, Mario
    MOVEMENT DISORDERS, 2023, 38 (04) : 626 - 635
  • [5] Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa
    Cilia, Roberto
    Cereda, Emanuele
    Akpalu, Albert
    Sarfo, Fred Stephen
    Cham, Momodou
    Laryea, Ruth
    Obese, Vida
    Oppon, Kenneth
    Del Sorbo, Francesca
    Bonvegna, Salvatore
    Zecchinelli, Anna Lena
    Pezzoli, Gianni
    BRAIN, 2020, 143 : 2490 - 2501
  • [6] Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa
    Cilia, Roberto
    Cereda, Emanuele
    Akpalu, Albert
    Sarfo, Fred Stephen
    Cham, Momodou
    Laryea, Ruth
    Obese, Vida
    Oppon, Kenneth
    Del Sorbo, Francesca
    Bonvegna, Salvatore
    Zecchinelli, Anna Lena
    Pezzoli, Gianni
    BRAIN, 2020, 143 (08) : 2490 - 2501
  • [7] Cognitive and Motor Function in Long-Duration PARKIN-Associated Parkinson Disease
    Alcalay, Roy N.
    Caccappolo, Elise
    Mejia-Santana, Helen
    Tang, Ming Xin
    Rosado, Llency
    Reilly, Martha Orbe
    Ruiz, Diana
    Louis, Elan D.
    Comella, Cynthia L.
    Nance, Martha A.
    Bressman, Susan B.
    Scott, William K.
    Tanner, Caroline M.
    Mickel, Susan F.
    Waters, Cheryl H.
    Fahn, Stanley
    Cote, Lucien J.
    Frucht, Steven J.
    Ford, Blair
    Rezak, Michael
    Novak, Kevin E.
    Friedman, Joseph H.
    Pfeiffer, Ronald F.
    Marsh, Laura
    Hiner, Bradley
    Payami, Haydeh
    Molho, Eric
    Factor, Stewart A.
    Nutt, John G.
    Serrano, Carmen
    Arroyo, Maritza
    Ottman, Ruth
    Pauciulo, Michael W.
    Nichols, William C.
    Clark, Lorraine N.
    Marder, Karen S.
    JAMA NEUROLOGY, 2014, 71 (01) : 62 - 67
  • [8] Grey matter atrophy in Parkinson's disease with long-duration response
    Donzuso, G.
    Sciacca, G.
    Mostile, G.
    Nicoletti, A.
    Zappia, M.
    MOVEMENT DISORDERS, 2019, 34 : S786 - S786
  • [9] Grey matter atrophy in Parkinson's disease with long-duration response
    Donzuso, G.
    Sciacca, G.
    Mostile, G.
    Nicoletti, A.
    Zappia, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 153 - 153
  • [10] Apomorphine infusion and the long-duration response to levodopa in advanced Parkinson's disease
    Stocchi, F
    Berardelli, A
    Vacca, L
    Barbato, L
    Monge, A
    Nordera, G
    Ruggieri, S
    CLINICAL NEUROPHARMACOLOGY, 2003, 26 (03) : 151 - 155